BioNTech eyes vaccine for 12-15 year olds in Europe from June
BioNTech said on Thursday that it expected its Covid-19 vaccine, jointly developed with
, to be available to 12 to 15-year-olds in Europe from June. The German firm’s CEO Ugur Sahin told Der Spiegel weekly that it was “in the final stretches” of preparing its submission for European regulatory approval.
The evaluation of the trial data “takes four to six weeks on average”, he added.
Vaccinating children is seen as a crucial next step toward herd immunity and ending the pandemic.
The prospect of getting older children inoculated before the next school year starts would also relieve the strain on parents who are juggling the demands of homeschooling while keeping up with jobs. “It’s very important to enable children a return to their normal school lives and allow them to meet with family and friends,” Sahin told Spiegel.
Published at Thu, 29 Apr 2021 18:15:46 +0000
Attribution – For more Information here is the Article Post Source: https://economictimes.indiatimes.com/news/international/world-news/biontech-eyes-vaccine-for-12-15-year-olds-in-eu-from-june/articleshow/82315994.cms